<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">Hemostatic disorders</z:e> can be found in approximately 90% of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, but clinical expression in only 15% </plain></SENT>
<SENT sid="1" pm="."><plain>Hemorrhagic complications are more frequent in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath>; <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> are often associated with <z:e sem="disease" ids="C0149871" disease_type="Disease or Syndrome" abbrv="">deep venous thromboses</z:e> (DVP) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0005521'>Disseminated intravascular coagulation</z:hpo> syndrome (DICS) can be latent or <z:hpo ids='HP_0011009'>acute</z:hpo>, and has various clinical presentations, occurring in the course of many serious conditions including <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients have higher morbidity and mortality </plain></SENT>
<SENT sid="4" pm="."><plain>Irrespective of the etiology, DICS can be revealed by a wide variety of clinical manifestations, from mild biological hemostasis disorders, to intravascular or extravascular microthromboses or lethal hemorrhagic events </plain></SENT>
<SENT sid="5" pm="."><plain>We report the case of a 45-year-old female with <z:e sem="disease" ids="C0007131" disease_type="Neoplastic Process" abbrv="NSCLC">non-small-cell lung cancer</z:e> with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> at diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain>The patient developed and finally died of numberous <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> subsequent to DICS </plain></SENT>
<SENT sid="7" pm="."><plain>This case illustrates some rather rare complications of DICS and offers the opportunity to discuss the main therapeutic goal in this situation, i.e. to modulate the disproportionate production of thrombin, inducing thromboses and/or <z:mp ids='MP_0001914'>hemorrhages</z:mp> by consumption of the cellular and plasmatic coagulation factors </plain></SENT>
<SENT sid="8" pm="."><plain>This means a symptomatic and mostly etiologic treatment, especially chemotherapy which can in itself provoke <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
</text></document>